Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel

Molecular Cell

Volumn 14, Issue 2, 2004, Pages 259-267

  Hsu, Kate ^a,b   Seharaseyon, Jegatheesan ^b,d   Dong, Peihong ^b   Bour, Stephan ^c   Marbán, Eduardo ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d US Patent and Trademark Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; VPU PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR EVOLUTION; PREDICTION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; STRUCTURAL HOMOLOGY; VIRUS CELL INTERACTION; VIRUS PARTICLE;

AMINO ACID SEQUENCE; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; BLOTTING, WESTERN; CELL LINE; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, VPU; GENES, VIRAL; HELA CELLS; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; ION CHANNELS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; PRECIPITIN TESTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 1942502838     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00183-2     Document Type: Article

References (48)

1. Abbott G.W., Goldstein S.A. A superfamily of small potassium channel subunits. form and function of the MinK-related peptides (MiRPs) Q. Rev. Biophys. 31:1998;357-398.
2. Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H., Timothy K.W., Keating M.T., Goldstein S.A. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 97:1999;175-187.
3. Akari H., Bour S., Kao S., Adachi A., Strebel K. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J. Exp. Med. 194:2001;1299-1311.
4. Babila T., Moscucci A., Wang H., Weaver F.E., Koren G. Assembly of mammalian voltage-gated potassium channels. evidence for an important role of the first transmembrane segment Neuron. 12:1994;615-626.
5. Backx P.H., Marbán E. Background potassium current active during the plateau of the action potential in guinea pig ventricular myocytes. Circ. Res. 72:1993;890-900.
6. Bagasra O., Lavi E., Bobroski L., Khalili K., Pestaner J.P., Tawadros R., Pomerantz R.J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals. identification by the combination of in situ polymerase chain reaction and immunohistochemistry AIDS. 10:1996;573-585.
7. Bour S., Strebel K. The HIV-1 Vpu protein. a multifunctional enhancer of viral particle release Microbes Infect. 5:2003;1029-1039.
8. Bour S., Boulerice F., Wainberg M.A. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J. Virol. 65:1991;6387-6396.
9. Bour S., Perrin C., Strebel K. Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. J. Biol. Chem. 274:1999;33800-33806.
10. Bour S., Perrin C., Akari H., Strebel K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J. Biol. Chem. 276:2001;15920-15928.
11. Buonocore L., Rose J.K. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature. 345:1990;625-628.
12. Coady M.J., Daniel N.G., Tiganos E., Allain B., Friborg J., Lapointe J.Y., Cohen E.A. Effects of Vpu expression on Xenopus oocyte membrane conductance. Virology. 244:1998;39-49.
13. Czirjak G., Enyedi P. Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J. Biol. Chem. 277:2002;5426-5432.
14. Deutsch C. Potassium channel ontogeny. Annu. Rev. Physiol. 64:2002;19-46.
15. Duprat F., Lesage F., Fink M., Reyes R., Heurteaux C., Lazdunski M. TASK, a human background K+ channel to sense external pH variations near physiological pH. EMBO J. 16:1997;5464-5471.
16. Folco E., Mathur R., Mori Y., Buckett P., Koren G. A cellular model for long QT syndrome. Trapping of heteromultimeric complexes consisting of truncated Kv1.1 potassium channel polypeptides and native Kv1.4 and Kv1.5 channels in the endoplasmic reticulum. J. Biol. Chem. 272:1997;26505-26510.
17. Gonzalez M.E., Carrasco L. The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability. Biochemistry. 37:1998;13710-13719.
18. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell. basic science as a passport to future therapy Nat. Med. 8:2002;673-680.
19. Hoppe U.C., Johns D.C., Marbán E., O'Rourke B. Manipulation of cellular excitability by cell fusion. effects of rapid introduction of transient outward K+ current on the guinea pig action potential Circ. Res. 84:1999;964-972.
20. Johns D.C., Nuss H.B., Marbán E. Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs. J. Biol. Chem. 272:1997;31598-31603.
21. Kim D., Fujita A., Horio Y., Kurachi Y. Cloning and functional expression of a novel cardiac two-pore background K+ channel (cTBAK-1). Circ. Res. 82:1998;513-518.
22. Kim Y., Bang H., Kim D. TBAK-1 and TASK-1, two-pore K(+) channel subunits. kinetic properties and expression in rat heart Am. J. Physiol. 277:1999;H1669-H1678.
23. Klimkait T., Strebel K., Hoggan M.D., Martin M.A., Orenstein J.M. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64:1990;621-629.
24. Lakos Z., Somogyi B., Balazs M., Matko J., Damjanovich S. The effect of transmembrane potential on the dynamic behavior of cell membranes. Biochim. Biophys. Acta. 1023:1990;41-46.
25. Lamb R.A., Pinto L.H. Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles? Virology. 229:1997;1-11.
26. Lelkes P.I. Potential dependent riigidity changes in lipid membrane vesicles. Biochem. Biophys. Res. Commun. 90:1979;656-662.
27. Leonoudakis D., Gray A.T., Winegar B.D., Kindler C.H., Harada M., Taylor D.M., Chavez R.A., Forsayeth J.R., Yost C.S. An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum. J. Neurosci. 18:1998;868-877.
28. London B., Jeron A., Zhou J., Buckett P., Han X., Mitchell G.F., Koren G. Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc. Natl. Acad. Sci. USA. 95:1998;2926-2931.
29. Maldarelli F., Chen M.Y., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67:1993;5056-5061.
30. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., Benarous R. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell. 1:1998;565-574.
31. Marin M., Rose K.M., Kozak S.L., Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:2003;1398-1403.
32. McDonald T.V., Yu Z., Ming Z., Palma E., Meyers M.B., Wang K.W., Goldstein S.A., Fishman G.I. A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature. 388:1997;289-292.
33. Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J. Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome. Proc. Natl. Acad. Sci. USA. 99:2002;7986-7991.
34. Paul M., Mazumder S., Raja N., Jabbar M.A. Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J. Virol. 72:1998;1270-1279.
35. Pierson T.C., Zhou Y., Kieffer T.L., Ruff C.T., Buck C., Siliciano R.F. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76:2002;8518-8531.
36. Schubert U., Ferrer-Montiel A.V., Oblatt-Montal M., Henklein P., Strebel K., Montal M. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 398:1996;12-18.
37. Sesti F., Tai K.K., Goldstein S.A. MinK endows the I(Ks) potassium channel pore with sensitivity to internal tetraethylammonium. Biophys. J. 79:2000;1369-1378.
38. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:2003;1404-1407.
39. Shimbo K., Brassard D.L., Lamb R.A., Pinto L.H. Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes. Biophys. J. 69:1995;1819-1829.
40. Sinkovics J., Horvath J., Horak A. The origin and evolution of viruses (a review). Acta Microbiol. Immunol. Hung. 45:1998;349-390.
41. Stopak K., de Noronha C., Yonemoto W., Greene W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell. 12:2003;591-601.
42. Strebel K., Klimkait T., Martin M.A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 241:1988;1221-1223.
43. Strebel K., Klimkait T., Maldarelli F., Martin M.A. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 63:1989;3784-3791.
44. Talley E.M., Solorzano G., Lei Q., Kim D., Bayliss D.A. Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci. 21:2001;7491-7505.
45. Vink C., Beisser P.S., Bruggeman C.A. Molecular mimicry by cytomegaloviruses. Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines. Intervirology. 42:1999;342-349.
46. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:1992;7193-7200.
47. Winston J.A., Bruggeman L.A., Ross M.D., Jacobson J., Ross L., D'Agati V.D., Klotman P.E., Klotman M.E. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N. Engl. J. Med. 344:2001;1979-1984.
48. Wray V., Federau T., Henklein P., Klabunde S., Kunert O., Schomburg D., Schubert U. Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. Int. J. Pept. Protein Res. 45:1995;35-43.